
ROCHESTER, Minn. — October 22, 2012. Imagine reprogramming skin and blood cells to heal an injured organ. Or, consider the potential benefits of all patients knowing their personal genomes and being able to customize health care to their particular genes.
These types of health care improvements are the ideal end products of translational research. The October issue of Mayo Clinic Health Letter includes a Special Report on translational research and how it is leading to breakthrough treatments.
Mayo Clinic is a leader in translational research, which can be broadly described as a research cycle. First, a problem is observed in the health care system. Researchers study the problem. Then, they retool discoveries into solutions that benefit patients.
Examples include:
Mayo Clinic Health Letter is an eight-page monthly newsletter of reliable, accurate and practical information on today's health and medical news. To subscribe, please call 800-333-9037 (toll-free), extension 9771, or visit Mayo Clinic Health Letter Online.
###
About Mayo Clinic:
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, www.mayoclinic.org and newsnetwork.mayoclinic.org.
Media Contact: Ginger Plumbo, 507-284-5005 (days), newsbureau@mayo.edu
Mayo Clinic celebrated the graduation of the next generation of physicians and scientists. In a combined ceremony in Rochester, Minnesota, on Friday, May 19, students ...
ROCHESTER, Minn. — Donald M. Remy, former deputy secretary of the Department of Veterans Affairs, was elected to the Mayo Clinic Board of Trustees at ...
Facility aims to manufacture next generation of radiopharmaceuticals ROCHESTER, Minn. — Nucleus RadioPharma, a radiopharmaceutical company founded by Eclipse and Mayo Clinic, announced today it has ...